Rabbit IgG anti-Rat IgG (F(ab)2)-FITC, MinX none

Artikelnummer: DNA-SEC-183498
Artikelname: Rabbit IgG anti-Rat IgG (F(ab)2)-FITC, MinX none
Artikelnummer: DNA-SEC-183498
Hersteller Artikelnummer: SEC-183498
Alternativnummer: DNA-SEC-183498
Hersteller: dianova
Wirt: Rabbit
Kategorie: Antikörper
Applikation: FLISA,FACS,IF
Spezies Reaktivität: Rat
Immunogen: Rat IgG F(ab)2 fragment
Konjugation: FITC
Alternative Synonym: Rabbit Anti-Rat IgG F(ab)2 fluorescein Conjugated Antibody, Rabbit Anti-Rat IgG Fab2 fluorescein Conjugated Antibody, Rabbit Anti-Rat IgG Fab2 Fragment Antibody FITC Conjugation
Format: IgG
Spezifität: IgG (F(ab')2)
Minimale Kreuzreaktivität (MinX): no cross-adsorbtion
Anti-Rat IgG F(ab)2 Antibody generated in rabbit recognizes the dimeric Fab portion of the rat IgG molecule. Rat IgG F(ab)2 is a proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme pepsin under controlled conditio
Klonalität: Polyclonal
Konzentration: 2.0 mg/mL
Isotyp: Ig
Puffer: 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Reinheit: This product was prepared from monospecific antiserum by immunoaffinity chromatography using Rat IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.   Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Fluorescein, anti-Rabbit Serum, Rat IgG, Rat IgG F(ab’)2 and Rat Serum.  No reaction was observed against Rat IgG F(c).
Formulierung: Lyophilized
Formel: 10 mM NaPO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% NaN3
Target-Kategorie: Rat
Antibody Type: Secondary Antibody
Application Verdünnung: FLISA Dilution: 1:10,000 - 1:50,000, Flow Cytometry Dilution: 1:500 - 1:2,500, Fluorochrome Protein Value: 1.4, IF Microscopy Dilution: 1:1,000 - 1:5,000
Anwendungsbeschreibung: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.